Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...

Improvements in optimal medical therapy for patients with heart failure with reduced ejection fraction (HFrEF) have helped reduce the risk of sudden cardiac death (SCD)—in the modern era, though, just ...

San Clemente-based cardiac device company AtaCor Medical announced a collaboration with Abbott Laboratories to develop a next ...

Hypokalemia and even low-normal plasma potassium levels increase the risk of ventricular arrhythmias among patients with cardiovascular disease. An assessment of a strategy of actively increasing ...

Learn about the groundbreaking approach in treating the heart with radiation, improving lives through advanced therapy ...

MADRID, Spain—Increasing low potassium levels improves clinical outcomes among patients with cardiovascular disease and a high risk for ventricular arrhythmias, the randomized POTCAST trial shows.